CCLDO
CareCloud, Inc.
NASDAQ · Healthcare · Medical - Healthcare Information Services · US
$27.44
+0.00%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 124.1M | 120.5M | 110.8M | 117.1M | 138.8M |
| Cost of Revenue | 84.8M | 64.5M | 60.8M | 70.8M | 84.4M |
| Gross Profit | 39.3M | 56.0M | 50.0M | 46.2M | 54.4M |
| Operating Expenses | |||||
| R&D Expense | 7.6M | 6.4M | 3.8M | 4.7M | 4.4M |
| SG&A Expense | 24.7M | 23.2M | 22.4M | 31.1M | 33.6M |
| General & Admin Expense | 19.6M | 18.4M | 16.1M | 21.5M | 23.8M |
| Selling & Marketing Expense | 5.1M | 4.8M | 6.2M | 9.7M | 9.8M |
| Other Expenses | (3.5M) | 15.0M | 14.7M | 57.5M | 9.8M |
| Total Operating Expenses | 28.8M | 44.5M | 40.9M | 93.4M | 47.8M |
| Cost and Expenses | 113.6M | 109.0M | 101.7M | 164.2M | 132.2M |
| Operating Income (EBIT) | 10.5M | 11.5M | 9.1M | (47.1M) | 6.6M |
| Non-Operating | |||||
| Interest Income | 174.0K | 206.0K | 88.0K | 154.0K | 41.0K |
| Interest Expense | 287.0K | 287.0K | 900.0K | 1.2M | 405.0K |
| Net Interest Income | (113.0K) | (81.0K) | (812.0K) | (1.0M) | (364.0K) |
| Other Non-Op Income/Expense | (553.0K) | (500.0K) | (1.1M) | (1.9M) | (1.0M) |
| Non-Operating Income (excl Interest) | 53.0K | 213.0K | 210.0K | 729.0K | 596.0K |
| EBT (Pre-Tax Income) | 10.0M | 11.0M | 8.0M | (49.0M) | 5.6M |
| Income Tax Expense | 210.0K | 199.0K | 160.0K | (364.0K) | 177.0K |
| Bottom Line | |||||
| Net Income | 9.8M | 10.8M | 7.9M | (48.7M) | 5.4M |
| Earnings from Cont. Ops | 9.8M | 10.8M | 7.9M | (48.7M) | 5.4M |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | 4.3M | 3.9M | (4.5M) | (64.3M) | (10.1M) |
| Per Share | |||||
| Basic EPS | $0.08 | $0.10 | ($0.28) | ($4.11) | ($0.67) |
| Diluted EPS | $0.11 | $0.10 | ($0.28) | ($4.11) | ($0.67) |
| Revenue Per Share | $2.92 | $0.32 | $6.86 | $7.47 | $9.19 |
| Shares | |||||
| Basic Shares Outstanding | 42.5M | 377.9M | 16.1M | 15.7M | 15.1M |
| Diluted Shares Outstanding | 42.5M | 379.5M | 16.1M | 15.7M | 15.1M |
| Profitability Metrics | |||||
| EBITDA | 28.3M | 28.3M | 25.0M | (31.3M) | 21.0M |
| D&A | 17.8M | 17.0M | 16.1M | 16.6M | 15.0M |
| EBIT | 10.5M | 11.3M | 8.9M | (47.8M) | 6.0M |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Mar 1, 2026